Top Markets
#1 PulseChain PulseChain +48.38%
#2 Ergo Ergo +22.78%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +17.06%
#4 RedStone RedStone +15.48%
#5 SkyAI SkyAI +11.00%
#6 Lighter Lighter +9.58%
#7 MarsCoin MarsCoin +9.07%
#8 OPENLOOT OPENLOOT +8.87%
#9 Monad Monad +8.43%
#10 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +7.93%
Coin of the day
PulseChain PulseChain
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Angion Biomedica Corp. Angion Biomedica Corp.

Angion Biomedica Corp.

ANGN
Rang in aandelen #27858
Angion Biomedica Corp. operates as a biopharmaceutical enterprise,... Angion Biomedica Corp. operates as a biopharmaceutical enterprise, concentrating its efforts on the identification, advancement, and market introduction of small molecule treatments for severe organ damage and scarring conditions. Its primary investigational compound, ANG-3070, is an orally administered tyrosine kinase receptor inhibitor currently being developed to address fibrotic ailments, particularly those impacting the kidneys and lungs. The company's product pipeline also features ANG-3777, a hepatocyte growth factor mimetic engineered to treat acute organ injuries like delayed graft function, in addition to initiatives for ROCK2 inhibitors targeting fibrotic diseases and a CYP11B2 inhibitor program. Established in 1998, Angion Biomedica Corp. maintains its headquarters in Uniondale, New York.
Aandeelprijs
$1.00
Laatst gesynchroniseerd: 2023-06-01
Marktkapitalisatie
$30.11M
Verandering (1 dag)
2.04%
Verandering (1 jaar)
0.00%
Land
US
Handel Angion Biomedica Corp. (ANGN)

Categorie

Healthcare
Aandelsplitsingen voor Angion Biomedica Corp. (ANGN)
Het aandeel Angion Biomedica Corp. (symbool: ANGN) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 20, 2026.
Eén aandeel ANGN dat vóór Aug 20, 2026 werd gekocht, staat nu gelijk aan 0 aandelen ANGN.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH